Viewing StudyNCT00127569



Ignite Creation Date: 2024-05-05 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00127569
Status: TERMINATED
Last Update Posted: 2007-01-12
First Post: 2005-08-04

Brief Title: Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Organization: French National Agency for Research on AIDS and Viral Hepatitis

Organization Data

Organization: French National Agency for Research on AIDS and Viral Hepatitis
Class: OTHER_GOV
Study ID: ANRS 117 CastlemaB
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Lead Sponsor Class: OTHER_GOV
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Hoffmann-La Roche INDUSTRY